MicroRNAs in diagnosis of ovarian cancer. Potential, Challenges, Pitfalls
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10320336" target="_blank" >RIV/00216208:11110/15:10320336 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
MicroRNAs in diagnosis of ovarian cancer. Potential, Challenges, Pitfalls
Original language description
Ovarian cancer is the most deadly gynecological cancer. High mortality of the patients is usually associated with the progression of the disease. Most of the patients are diagnosed within the advanced stages due to lacking relevant diagnostic and screening markers. Achieving the diagnosis in the early stages of disease is a prerequisite of the more successful treatment of ovarian cancer. In this review, we focus on the recent progress in research focused on circulating, particularly cell-free microRNAsexpression in diagnostically relevant samples such as blood, plasma/serum and urine. More research will be needed to establish circulating and extracellular microRNAs as the novel diagnostic markers for ovarian cancer.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Handbook on Ovarian Cancer: Risk Factors, Therapies and Prognosis
ISBN
978-1-63483-925-9
Number of pages of the result
18
Pages from-to
45-62
Number of pages of the book
247
Publisher name
Nova Science Publishers
Place of publication
New York
UT code for WoS chapter
—